This brand name is authorized in Finland, Poland
The drug PIMAFUCIN contains one active pharmaceutical ingredient (API):
|
1
Natamycin
UNII 8O0C852CPO - NATAMYCIN
|
|
Natamycin is a tetraene polyene antibiotic derived from Streptomyces natalensis. It possesses in vitro activity against a variety of yeast and filamentous fungi, including Candida, Aspergillus, Cephalosporium, Fusarium and Penicillium. The mechanism of action appears to be through binding of the molecule to the sterol moiety of the fungal cell membrane. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| D01AA02 | Natamycin | D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AA Antibiotics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 179414 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100053111, 100053128, 100287926, 100324432, 100335602, 100335631 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
